Halo Therapeutics

Bristol, United Kingdom

Halo Therapeutics develops antivirals to prevent users from sickness.

$1.9M raised

May 2023

Seed

Biotechnology Health Care Life Science Medical Therapeutics

Top Investors

Development Bank of Wales KBA Group Jonathan Matlock

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Halo Therapeutics

How much funding has Halo Therapeutics raised?

Halo Therapeutics has raised $1.9M in total funding. The most recent round was Seed. The last funding was announced in May 2023.

Who are Halo Therapeutics's investors?

Halo Therapeutics's investors include Development Bank of Wales, KBA Group, Jonathan Matlock.

Where is Halo Therapeutics headquartered?

Halo Therapeutics is headquartered in Bristol, United Kingdom.

What does Halo Therapeutics do?

Halo Therapeutics develops antivirals to prevent users from sickness.

What stage is Halo Therapeutics at?

Halo Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 17, 2023.

MLA

"Halo Therapeutics — Funding & Investors." VCBacked, May 17, 2023, https://www.vcbacked.co/company/halo-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2023). Halo Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/halo-therapeutics

Wikipedia (cite web)

{{cite web |title=Halo Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/halo-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 17, 2023.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K